Annovis Bio Statistics

Total Valuation

Annovis Bio has a market cap or net worth of $73.17 million. The enterprise value is $58.95 million.

Market Cap	73.17M
Enterprise Value	58.95M

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026, before market open.

Earnings Date	Aug 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Annovis Bio has 42.54 million shares outstanding. The number of shares has increased by 66.78% in one year.

Current Share Class	42.54M
Shares Outstanding	42.54M
Shares Change (YoY)	+66.78%
Shares Change (QoQ)	+8.87%
Owned by Insiders (%)	11.48%
Owned by Institutions (%)	13.53%
Float	37.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	15.70
P/TBV Ratio	23.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.27

Current Ratio	1.27
Quick Ratio	1.11
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -301.13% and return on invested capital (ROIC) is -190.05%.

Return on Equity (ROE)	-301.13%
Return on Assets (ROA)	-120.18%
Return on Invested Capital (ROIC)	-190.05%
Return on Capital Employed (ROCE)	-1,196.76%
Weighted Average Cost of Capital (WACC)	10.79%
Revenue Per Employee	n/a
Profits Per Employee	-$5.85M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.89% in the last 52 weeks. The beta is 1.19, so Annovis Bio's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	-24.89%
50-Day Moving Average	1.94
200-Day Moving Average	2.55
Relative Strength Index (RSI)	41.92
Average Volume (20 Days)	1,071,676

Short Selling Information

The latest short interest is 4.80 million, so 11.29% of the outstanding shares have been sold short.

Short Interest	4.80M
Short Previous Month	4.67M
Short % of Shares Out	11.29%
Short % of Float	12.76%
Short Ratio (days to cover)	3.56

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-41.32M
Pretax Income	-40.92M
Net Income	-40.92M
EBITDA	n/a
EBIT	-41.32M
Earnings Per Share (EPS)	-$1.77

Full Income Statement

Balance Sheet

The company has $14.22 million in cash and n/a in debt, giving a net cash position of $14.22 million or $0.33 per share.

Cash & Cash Equivalents	14.22M
Total Debt	n/a
Net Cash	14.22M
Net Cash Per Share	$0.33
Equity (Book Value)	3.13M
Book Value Per Share	0.11
Working Capital	3.45M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-26.53M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Annovis Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-66.78%
Shareholder Yield	-66.78%
Earnings Yield	-55.93%
FCF Yield	n/a

Analyst Forecast

The average price target for Annovis Bio is $12.50, which is 626.74% higher than the current price. The consensus rating is "Buy".

Price Target	$12.50
Price Target Difference	626.74%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1